Glaxosmithkline Pharmaceuticals Ltd.
Research Glaxosmithkline Pharmaceuticals Ltd. (GLAXO.NS) on Bullrun: market cap INR 434.71B, P/E 40.7, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGLAXO.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyINR
- Market capINR 434.71B
- P/E40.7
- Dividend yield2.2%
- Financial periodQ2 2026
- RevenueINR 9.38B
- Net incomeINR 2.37B
- Gross margin65.1%
Valuation Snapshot
latest market cap is INR 434.71B; P/E is 40.7; dividend yield is 2.2%.
Peer valuation comparison
Latest P/E is 40.7x versus a Healthcare sector median of 21.74x (87.2% above).
Latest dividend yield is 2.22% versus a Healthcare sector median of 2.4% (7.5% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 434.71B | 40.7 | 2.2% | 57 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 57 INR, yield 2.2%.
About Glaxosmithkline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Glaxosmithkline Pharmaceuticals Ltd.'s market cap?
Glaxosmithkline Pharmaceuticals Ltd.'s market capitalization is INR 434.71B.
What is Glaxosmithkline Pharmaceuticals Ltd.'s P/E ratio?
Glaxosmithkline Pharmaceuticals Ltd.'s price-to-earnings (P/E) ratio is 40.7.
Does Glaxosmithkline Pharmaceuticals Ltd. pay a dividend?
Glaxosmithkline Pharmaceuticals Ltd. has a dividend yield of 2.2%.
What does Glaxosmithkline Pharmaceuticals Ltd. do?
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide.